XOMA Royalty (XOMA) Amortizatization of Intangibles (2012 - 2013)

XOMA Royalty (XOMA) reported Amortizatization of Intangibles of $400000.0 for Q3 2013, little changed on a YoY basis from $400000.0 in Q3 2012, and little changed sequentially from $400000.0 in Q3 2012.

XOMA Royalty (XOMA) Amortizatization of Intangibles (2012 - 2013) Analysis & Trends

XOMA Royalty (XOMA) has 2 years of Amortizatization of Intangibles data on file, last reported at $400000.0 in Q3 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2013 400,000.00
Sep 30, 2013 400,000.00
Sep 30, 2012 400,000.00
Sep 30, 2012 400,000.00